Cargando…

Concurrent Hearing and Genetic Screening among Newborns in Ningbo, China

OBJECTIVE: To detect the carrier rates of deafness gene variants in populations in Ningbo and analyze the risk of hereditary hearing loss through concurrent hearing and genetic screening tests. METHODS: Two thousand one hundred and seventy-four newborns were enrolled from November 2018 to August 201...

Descripción completa

Detalles Bibliográficos
Autores principales: Guomei, Cao, Luyan, Zhang, Lingling, Dai, Chunhong, Huang, Shan, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763501/
https://www.ncbi.nlm.nih.gov/pubmed/35047053
http://dx.doi.org/10.1155/2022/1713337
_version_ 1784633949687906304
author Guomei, Cao
Luyan, Zhang
Lingling, Dai
Chunhong, Huang
Shan, Chen
author_facet Guomei, Cao
Luyan, Zhang
Lingling, Dai
Chunhong, Huang
Shan, Chen
author_sort Guomei, Cao
collection PubMed
description OBJECTIVE: To detect the carrier rates of deafness gene variants in populations in Ningbo and analyze the risk of hereditary hearing loss through concurrent hearing and genetic screening tests. METHODS: Two thousand one hundred and seventy-four newborns were enrolled from November 2018 to August 2019. All subjects underwent hearing screening and newborn deafness genetic screening with 15 variants in 4 genes, and the positive sites were simultaneously verified by sequencing. RESULTS: The total carrier rate of genetic variants in Ningbo reached 4.32%, when GJB2 c.235delC was the variant with the highest prevalence (2.12%), approximately accounting for 48.9% of the total carrier frequency. The carrier frequency of SLC26A4 c.919-2A>G was 0.87%, while the most common variant in mitochondrial DNA (mtDNA) MT-RNR1 gene was m.1555A>G, and its carrier frequency was 0.184%. In the OAE testing, 92 newborns passing hearing screening were tested positively for variants in 4 genes, and 2 of 42 newborns who failed in the first hearing test were found to mutate in 4 genes. CONCLUSION: Herein, the results concerning the carrier rates for deafness gene mutations of Ningbo population are reported. Our study is beneficial to the insight into the deafness genomic epidemiology for deafness genes in Ningbo population and provides the reference for healthcare in Ningbo.
format Online
Article
Text
id pubmed-8763501
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-87635012022-01-18 Concurrent Hearing and Genetic Screening among Newborns in Ningbo, China Guomei, Cao Luyan, Zhang Lingling, Dai Chunhong, Huang Shan, Chen Comput Math Methods Med Research Article OBJECTIVE: To detect the carrier rates of deafness gene variants in populations in Ningbo and analyze the risk of hereditary hearing loss through concurrent hearing and genetic screening tests. METHODS: Two thousand one hundred and seventy-four newborns were enrolled from November 2018 to August 2019. All subjects underwent hearing screening and newborn deafness genetic screening with 15 variants in 4 genes, and the positive sites were simultaneously verified by sequencing. RESULTS: The total carrier rate of genetic variants in Ningbo reached 4.32%, when GJB2 c.235delC was the variant with the highest prevalence (2.12%), approximately accounting for 48.9% of the total carrier frequency. The carrier frequency of SLC26A4 c.919-2A>G was 0.87%, while the most common variant in mitochondrial DNA (mtDNA) MT-RNR1 gene was m.1555A>G, and its carrier frequency was 0.184%. In the OAE testing, 92 newborns passing hearing screening were tested positively for variants in 4 genes, and 2 of 42 newborns who failed in the first hearing test were found to mutate in 4 genes. CONCLUSION: Herein, the results concerning the carrier rates for deafness gene mutations of Ningbo population are reported. Our study is beneficial to the insight into the deafness genomic epidemiology for deafness genes in Ningbo population and provides the reference for healthcare in Ningbo. Hindawi 2022-01-10 /pmc/articles/PMC8763501/ /pubmed/35047053 http://dx.doi.org/10.1155/2022/1713337 Text en Copyright © 2022 Cao Guomei et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Guomei, Cao
Luyan, Zhang
Lingling, Dai
Chunhong, Huang
Shan, Chen
Concurrent Hearing and Genetic Screening among Newborns in Ningbo, China
title Concurrent Hearing and Genetic Screening among Newborns in Ningbo, China
title_full Concurrent Hearing and Genetic Screening among Newborns in Ningbo, China
title_fullStr Concurrent Hearing and Genetic Screening among Newborns in Ningbo, China
title_full_unstemmed Concurrent Hearing and Genetic Screening among Newborns in Ningbo, China
title_short Concurrent Hearing and Genetic Screening among Newborns in Ningbo, China
title_sort concurrent hearing and genetic screening among newborns in ningbo, china
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763501/
https://www.ncbi.nlm.nih.gov/pubmed/35047053
http://dx.doi.org/10.1155/2022/1713337
work_keys_str_mv AT guomeicao concurrenthearingandgeneticscreeningamongnewbornsinningbochina
AT luyanzhang concurrenthearingandgeneticscreeningamongnewbornsinningbochina
AT linglingdai concurrenthearingandgeneticscreeningamongnewbornsinningbochina
AT chunhonghuang concurrenthearingandgeneticscreeningamongnewbornsinningbochina
AT shanchen concurrenthearingandgeneticscreeningamongnewbornsinningbochina